The Real-Time Research Site Network
Revolutionize your clinical trials with Ryght AI. Our secure, AI-powered platform streamlines operations and shatters traditional timelines.
Join The Ryght Research Network and connect with a global ecosystem of thousands of trial sites in dozens of countries, plus leading sponsors, CROs and Ryght-powered tech companies.
We are building and AI-enabling, the largest site network in the world to solve the core upstream bottlenecks in clinical trials — finding the Ryght studies for the Ryght sites at the Ryght time.

For Sponsors
Whether it’s to get funding for your study or to get to work with your CRO and start enrolling, our generative AI platform and powerful, global site network can help you identify, select and activate the best sites with the least competition and just start enrolling - all faster than current methods.

For Research Sites
Your lifeblood is new trials, but you are drowning in data requests. Why can't you find trials that just work for you? Why can't you match patients without expensive software integrations?
Now you can. Join the Ryght Research Network. Get the tech for free and let us bring you sponsored trials. No EMR integrations and no PHI required. It's that easy.
Global Site Network
We are deploying our Generative AI platform and research applications to a global network of research sites, then providing access, activation and efficiency to biotech, pharma and CRO partners worldwide.
In a fully AI connected world, friction can disappear, drugs can be approved, and lives can be saved.

Trusted by healthcare and clinical
research companies worldwide
referrals, the Ryght Research Network will allow
us to focus more on advancing patient
care and less on administrative burden while
running the trials that are most likely to succeed."
M.D, Ph.D., Associate Dean of Clinical Research
Keck School of Medicine of the University of Southern California
clinical trials from site selection to activation
and enrollment, ultimately speeding up time to
market for our biopharma clients.”
Executive Vice President and Global Head of Clinical Research
QPS
CEO
Avance Clinical
Interim Director of the Institute for Photonics and Advanced Sensing (IPAS)
Adelaide University